LA GRANDE PHARMACIE DE CATALOGNE : revenue, balance sheet and financial ratios

LA GRANDE PHARMACIE DE CATALOGNE is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PERPIGNAN (66000), this company of category PME shows in 2020 a revenue of 6.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LA GRANDE PHARMACIE DE CATALOGNE (SIREN 811402627)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue N/C N/C N/C N/C 6 052 226 € 5 981 005 € 5 747 827 € 5 211 143 € 4 780 681 € 2 052 497 €
Net income 498 626 € 548 922 € 696 042 € 962 246 € 557 698 € 567 470 € 525 229 € 511 625 € 428 277 € 215 985 €
EBITDA N/C N/C N/C N/C 616 803 € 610 571 € 569 628 € 541 599 € 420 041 € 227 485 €
Net margin N/C N/C N/C N/C 9.2% 9.5% 9.1% 9.8% 9.0% 10.5%

Revenue and income statement

In 2024, LA GRANDE PHARMACIE DE CATALOGNE generates positive net income of 499 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 216 k€ -> 499 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

498 626 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 79%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3.755%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

79.179%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

28.4%

Solvency indicators evolution
LA GRANDE PHARMACIE DE CATALOGNE

Sector positioning

Debt ratio
3.75 2024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Excellent

In 2024, the debt ratio of LA GRANDE PHARMACIE DE CA... (3.75) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
79.18% 2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Excellent +8 pts over 3 years

In 2024, the financial autonomy of LA GRANDE PHARMACIE DE CA... (79.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 217.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

217.341

Liquidity indicators evolution
LA GRANDE PHARMACIE DE CATALOGNE

Sector positioning

Liquidity ratio
217.34 2024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good +27 pts over 3 years

In 2024, the liquidity ratio of LA GRANDE PHARMACIE DE CA... (217.34) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LA GRANDE PHARMACIE DE CATALOGNE

Positioning of LA GRANDE PHARMACIE DE CATALOGNE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of LA GRANDE PHARMACIE DE CATALOGNE is estimated at 6 961 187 € (range 4 847 660€ - 10 414 334€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
4847k€ 6961k€ 10414k€
6 961 187 € Range: 4 847 660€ - 10 414 334€
NAF 5 année 2024

Valuation method used

Net Income Multiple
498 626 € × 14.0x = 6 961 188 €
Range: 4 847 661€ - 10 414 335€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare LA GRANDE PHARMACIE DE CATALOGNE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about LA GRANDE PHARMACIE DE CATALOGNE

What is the revenue of LA GRANDE PHARMACIE DE CATALOGNE ?

The revenue of LA GRANDE PHARMACIE DE CATALOGNE in 2020 is 6.1 M€.

Is LA GRANDE PHARMACIE DE CATALOGNE profitable?

Yes, LA GRANDE PHARMACIE DE CATALOGNE generated a net profit of 499 k€ in 2024.

Where is the headquarters of LA GRANDE PHARMACIE DE CATALOGNE ?

The headquarters of LA GRANDE PHARMACIE DE CATALOGNE is located in PERPIGNAN (66000), in the department Pyrenees-Orientales.

Where to find the tax return of LA GRANDE PHARMACIE DE CATALOGNE ?

The tax return of LA GRANDE PHARMACIE DE CATALOGNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LA GRANDE PHARMACIE DE CATALOGNE operate?

LA GRANDE PHARMACIE DE CATALOGNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.